TSLA Tesla, Inc.
Price Chart
Executive Summary
UBS issued a double upgrade on April 14, moving the stock from Sell to Neutral, though the price target remained unchanged at $352 — representing 21% downside from the current $445.27. UBS has a 55% accuracy rate on 5,083 calls with a 4.6% average return, placing it below the top-tier firms covering this name. Consensus is mixed: 29 Buy (71%), 24 Hold, 8 Sell/Strong Sell out of 61 analysts. The mean target is $412.25, median $450. The stock trades above the mean target. Momentum is flat — zero upgrades or downgrades in the last 30 days. EPS revisions are trending negative: 30-day revisions down outnumber up 18-to-7 for the current fiscal year. Insider sales total ~$1.9M over two months from two executives, including a director. Institutional activity is mixed: Renaissance Technologies doubled its position (+220.9%) and Norges Bank initiated a new $17.1B stake, while Bank of America trimmed 28.2%. Short interest is elevated at 61% of float. The bottom line: UBS's call is contrarian (double upgrade from Sell) but from a below-average-accuracy firm, with a stagnant PT that implies downside — treat as a neutral signal, not a bullish catalyst.
Impact Score
Consensus & Targets
Out of 61 analysts covering the stock: 9 Strong Buy, 20 Buy, 24 Hold, 7 Sell, 1 Strong Sell. That's 29 Buy-rated (47.5%), 24 Hold (39.3%), and 8 Sell/Strong Sell (13.1%). Consensus leans bullish but is far from unanimous, with a significant hold contingent.
Current price: $445.27. Mean target: $412.25 (implied downside -7.4%). Median target: $450 (near current). High target: $600 (Wedbush). Low target: $123. UBS's $352 target sits well below the mean — the second-lowest among 41 analysts. The stock trades above both the mean and median, indicating the Street is already pricing in upside that UBS does not see.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-04-23 | UBS | maintain | Neutral | $364.00 |
| 2026-04-23 | Canaccord Genuity | maintain | Buy | $450.00 |
| 2026-04-23 | RBC Capital | maintain | Outperform | $475.00 |
| 2026-04-23 | TD Cowen | reiterate | Buy | $490.00 |
| 2026-04-23 | Cantor Fitzgerald | reiterate | Overweight | $510.00 |
| 2026-04-23 | Wedbush | reiterate | Outperform | $600.00 |
| 2026-04-23 | Mizuho | maintain | Outperform | $480.00 |
| 2026-04-23 | Needham | reiterate | Hold | — |
| 2026-04-22 | Cantor Fitzgerald | reiterate | Overweight | $510.00 |
| 2026-04-21 | Wedbush | reiterate | Outperform | $600.00 |
Zero analyst upgrades or downgrades in the last 30 days — no momentum. EPS revisions are negative: 30-day revisions down outnumber up 18-to-7 for the current fiscal year, and 19-to-3 for next year. Estimates are being revised lower across all periods, a bearish undercurrent.
Firm Track Record — UBS
UBS accuracy: 55% on 5083 calls | avg return: 4.6%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Jefferies | 100% | 3/3 | 53.8% | top tier |
| RBC Capital | 93% | 13/14 | 33.7% | top tier |
| Piper Sandler | 85% | 11/13 | 32.7% | top tier |
| Canaccord Genuity | 80% | 12/15 | 28.5% | top tier |
| Roth MKM | 80% | 4/5 | 29.9% | top tier |
| Oppenheimer | 80% | 4/5 | 26.6% | top tier |
| Citigroup | 80% | 4/5 | 19.3% | top tier |
| Cantor Fitzgerald | 79% | 27/34 | 31.7% | top tier |
| Goldman Sachs | 79% | 11/14 | 22.5% | top tier |
| Needham | 78% | 7/9 | 24.6% | top tier |
UBS has a 55% accuracy rate on 5,083 calls with a 4.6% average return — below the peer average. Top-tier firms on this name include Jefferies (100% on 3 calls, +53.8% avg return), RBC Capital (93% on 14, +33.7%), and Piper Sandler (85% on 13, +32.7%). UBS's track record is mediocre relative to these peers, reducing the weight of this double upgrade.
Earnings Estimates
Next earnings: Jul 21, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $0.45 | $0.26 — $0.59 | $24.6B | ↑9 ↓0 |
| +1q | $0.54 | $0.30 — $0.83 | $26.9B | ↑7 ↓0 |
| 0y | $2.05 | $1.35 — $3.19 | $102.3B | ↑14 ↓0 |
| +1y | $2.51 | $1.46 — $3.65 | $118.2B | ↑7 ↓0 |
Cross-Platform Signals
Insider sales: $1.9M in total from two executives (director Kathleen Wilson-Thompson sold ~$1M over two months; CTO Vaibhav Taneja sold $899K). No insider buys — a bearish divergence from the upgrade. Institutional activity is mixed: Renaissance Technologies doubled its position (+220.9%) and Norges Bank initiated a $17.1B stake, while Bank of America trimmed 28.2%. Short interest is 61% of float — extremely high, suggesting heavy bearish positioning that could fuel a squeeze if sentiment shifts. No congressional trades. Overall, insider selling and negative EPS revisions diverge from the upgrade signal.
Actionable Insight
UBS's double upgrade is a contrarian call from a below-average firm with a stagnant PT implying downside — do not treat as a bullish catalyst. The high short interest (61%) and insider selling create a tug-of-war; wait for a catalyst (earnings July 21) or a PT increase before acting.
Documents Analyzed
Report based on filing metadata.
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 14, 2026
7d ago
|
ANALYST-UPGRADE
| $364.04 $433.28 | ▲ +19.02% | ▲ +12.72% | $422.55 (+16.07%) |
|
May 1, 2026
20d ago
|
ANALYST-UPGRADE
| $452.22 $417.51 | ▼ −7.68% | ▼ −5.28% | $422.55 (−6.56%) |
|
Apr 30, 2026
20d ago
|
10-K/A
| — | awaiting T+20 | — | — |
|
Apr 23, 2026
28d ago
|
Court Ruling
| $373.62 $417.26 | ▲ +11.68% | ▲ +7.05% | $422.55 (+13.10%) |
|
Apr 22, 2026
28d ago
|
8-K
| $373.62 $417.26 | ▼ −11.68% | ▼ −7.05% | $422.55 (−13.10%) |
|
Apr 13, 2026
5w ago
|
Court Ruling
| $352.28 $445.03 | ▲ +26.33% | ▲ +18.60% | $422.55 (+19.95%) |
|
Apr 2, 2026
7w ago
|
8-K
| $360.45 $381.63 | ▲ +5.88% | ▼ −4.00% | $422.55 (+17.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access